Thermo Fisher Scientific Inc. ( TMO) - Stock Earnings
TMO Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| July 23, 2026 BeforeMarket | — / — | — | — / — | — |
TMO Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | 1.6 billion USD | 11.1 billion USD |
| 2025Q4 | 2.0 billion USD | 12.2 billion USD |
| 2026Q1 | 1.7 billion USD | 11.0 billion USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
TMO Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 6.0 billion USD | 42.9 billion USD |
| 2024 | 6.3 billion USD | 42.9 billion USD |
| 2025 | 6.7 billion USD | 44.6 billion USD |
| 2026 Est. | — | — |
TMO
List: Challengers
Price: $526.46
Dividend Yield: 0.35%
Forward Dividend Yield: 0.36%
Payout Ratio: 9.69%
Dividend Per Share: 1.88 USD
Earnings Per Share: 18.20 USD
P/E Ratio: 25.65
Exchange: NYQ
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 1.2 million
Ebitda: 1.6 billionMarket Capitalization: 192.4 billion
Average Dividend Frequency: 4
Years Paying Dividends: 15
DGR3: 13.58%
DGR5: 14.89%
DGR10: 10.75%